Indivior Pharmaceuticals (INDV) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $1.15
- Estimate
- $0.92
- Surprise
- +24.8%
- Revenue (period 2026-06-30)
- $343.0M
- Score at report (before → after)
- 6.8 → 6.9/10
Revenue source: xbrl.
How the report landed
Indivior Pharmaceuticals (INDV) beat the $0.92 estimate with diluted EPS of $1.15 — a large 24.8% upside surprise. TrendMatrix's engine moved from Buy (Wait) (6.8/10) to Hold at 6.9/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates INDV Hold at 6.0/10.
4 of the last 4 quarters beat the estimate; this quarter's +24.8% surprise compares with a +41.7% four-quarter average. Next scheduled report: 2026-11-05.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (4/4)
What argues against it
- Negative momentum
- Momentum score 1.4/10 — below 4.5 minimum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $35.17
- Price target
- $41.65
- Stop
- $33.30
- Upside to target
- +18.4%
- Reward-to-risk
- 3.1:1
The stock trades at 12.6× trailing but 7.1× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 19 — a level conventionally read as oversold.
Model outputs from TrendMatrix’s engine as of 2026-09-04 — shown for context, not personalized investment advice.
INDV at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Drug Manufacturers - Specialty & Generic
- Market cap
- $4.11B
- P/E (fwd)
- 7.1
- P/E (ttm)
- 12.6
- 52-week range
- $22.22–$42.81
- Off 52-week high
- 17.8%
- RSI (14)
- 19
- Volume vs avg
- 0.26×
- Score today
- 6.0/10